Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | NLRP3 | Q96P20 | 2/20 | 0.48 |
| ▸ | SOAT2 | O75908 | 1/20 | 0.47 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9754297 | 0.84 | KMT2A (0.57) | KMT2ALMNASMN1; SMN2LPAR1MEN1 | |
| SCHEMBL9470522 | 0.84 | SMN1; SMN2 (0.60) | KMT2ALMNASMN1; SMN2GAALPAR1 | |
| SCHEMBL19422608 | 0.83 | SMN1; SMN2 (0.55) | KMT2ALMNASMN1; SMN2MEN1TDP1 | |
| SCHEMBL31155743 | 0.82 | KMT2A (0.58) | KMT2ALMNASMN1; SMN2LPAR1MEN1 | |
| SCHEMBL9678499 | 0.80 | SMN1; SMN2 (0.53) | KMT2ALMNASMN1; SMN2MEN1TDP1 | |
| SCHEMBL462304 | 0.80 | LPAR1 (0.66) | KMT2ALMNASMN1; SMN2LPAR1MEN1 | |
| SCHEMBL6429941 | 0.80 | KMT2A (0.65) | KMT2ALMNASMN1; SMN2LPAR1MEN1 | |
| SCHEMBL8845511 | 0.79 | KMT2A (0.68) | KMT2ALMNASMN1; SMN2LPAR1MEN1 | |
| SCHEMBL1726368 | 0.79 | KMT2A (0.62) | KMT2ALMNASMN1; SMN2LPAR1MEN1 | |
| SCHEMBL30525296 | 0.79 | CETP (0.59) | KMT2ALMNAMEN1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11795315-B2 | Group 5 metal complexes for producing amine-functionalized polyolefins | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2023-10-24 | — | — | US | disclosed |
| CN-115207426-A | Boron-based negative electrode electrolyte and organic flow battery comprising same | 香港科技大学 | 2022-10-18 | — | — | CN | disclosed |
| WO-2022133594-A1 | METHODS FOR HYDROAMINOALKYLATION OF OLEFINS AND GROUP 4 METAL COMPLEXES USEFUL IN SUCH METHODS | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2022-06-30 | — | — | WO | disclosed |
| WO-2022133594-A1 | METHODS FOR HYDROAMINOALKYLATION OF OLEFINS AND GROUP 4 METAL COMPLEXES USEFUL IN SUCH METHODS | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2022-06-30 | — | — | WO | disclosed |
| US-9079869-B2 | Chiral disulfonimides | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2015-07-14 | — | — | US | disclosed |
| WO-2012040853-A1 | GROUP 5 METAL COMPLEXES USEFUL FOR AMINE FUNCTIONALIZATION AND SYNTHETIC PROCESS FOR MANUFACTURE THEREOF | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2012-04-05 | — | — | WO | disclosed |
| US-20110313150-A1 | CHIRAL DISULFONIMIDES | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2011-12-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110313150-A1 | CHIRAL DISULFONIMIDES | STS, SUDS3, SF1 | KMT2A 3397/4885LMNA 1831/4885SMN1; SMN2 1930/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.